Katie Overheim, Ph.D., serves as Director of Applied Infectious Disease and Director of the ABSL3 Facility at Lovelace Biomedical. She has a strong background in animal model development and efficacy testing, with a specialty in high-containment bacterial and viral models of infection. In addition to her 16-plus years of subject matter expertise in animal models of infectious disease, she has a strong operational background in facility management and regulatory compliance, making her an integral part of our Infectious Disease Program. Dr, Overheim received her Ph.D. in Biomedical Sciences, with a concentration on Microbiology and Immunology, from the University of North Texas Health Science Center in 2003. Dr. Overheim was part of the Lovelace team from 2007-2012 and rejoined Lovelace Biomedical in 2015.